Evidence map›Paper›PMID 19074586›Full record

ReviewEndocrine reviews2009

Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption.

Laura N Vandenberg, Maricel V Maffini, Carlos Sonnenschein, Beverly S Rubin, Ana M Soto

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrine reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 439 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
439citing papers in PubMed, 2 pooled it
61.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

439 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,391 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Protective Effect of Melatonin Against Bisphenol A Toxicity.International journal of molecular sciences · 2025
    Review

379 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Laura N VandenbergTufts University School of Medicine, Department of Anatomy and Cellular Biology, 136 Harrison Avenue, Boston, Massachusetts 02111, USA.
Maricel V Maffini
Carlos Sonnenschein
Beverly S Rubin
Ana M Soto
Tufts University · US

Funding

Mechanisms of developmental toxicity of Bisphenol-AR01ES008314 · NIEHS · TUFTS UNIVERSITY BOSTON · PI SOTO, ANA · 1996 to 2016
$6.8M
Does perinatal exposure to Bisphenol A contribute to adult obesityR21ES013884 · NIEHS · TUFTS UNIVERSITY BOSTON · PI RUBIN, BEVERLY SHARON · 2005 to 2007
$478k
Perinatal xenoestrogen exposure: epigenesis and neoplasiaR21ES015182 · NIEHS · TUFTS UNIVERSITY BOSTON · PI SOTO, ANA · 2006 to 2007
$462k
NIEHS NIH HHS ES013884NIEHS NIH HHS ES015182NIEHS NIH HHS ES08314NIEHS NIH HHS R01 ES008314NIEHS NIH HHS R21 ES013884NIEHS NIH HHS R21 ES015182
6 · The paper itself

Abstract

In 1991, a group of 21 scientists gathered at the Wingspread Conference Center to discuss evidence of developmental alterations observed in wildlife populations after chemical exposures. There, the term "endocrine disruptor" was agreed upon to describe a class of chemicals including those that act as agonists and antagonists of the estrogen receptors (ERs), androgen receptor, thyroid hormone receptor, and others. This definition has since evolved, and the field has grown to encompass hundreds of chemicals. Despite significant advances in the study of endocrine disruptors, several controversies have sprung up and continue, including the debate over the existence of nonmonotonic dose response curves, the mechanisms of low-dose effects, and the importance of considering critical periods of exposure in experimental design. One chemical found ubiquitously in our environment, bisphenol-A (BPA), has received a tremendous amount of attention from research scientists, government panels, and the popular press. In this review, we have covered the above-mentioned controversies plus six additional issues that have divided scientists in the field of BPA research, namely: 1) mechanisms of BPA action; 2) levels of human exposure; 3) routes of human exposure; 4) pharmacokinetic models of BPA metabolism; 5) effects of BPA on exposed animals; and 6) links between BPA and cancer. Understanding these topics is essential for educating the public and medical professionals about potential risks associated with developmental exposure to BPA and other endocrine disruptors, the design of rigorously researched programs using both epidemiological and animal studies, and ultimately the development of a sound public health policy.

Indexed as

AnimalsBenzhydryl CompoundsBisphenol A CompoundsDose-Response Relationship, DrugEndocrine DisruptorsEnvironmental ExposureExpert TestimonyGrowth and DevelopmentHumansNeoplasmsPhenolsUnited StatesUnited States Food and Drug AdministrationBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEndocrine DisruptorsPhenols

Identifiers

PMID19074586
PMCPMC2647705
OpenAlexW1967211742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.